Zelalem Eshete

Array ( [id] => 9806412 [patent_doc_number] => 20150018357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'CRYSTAL FORM OF (6S)-5-METHYLTETRAHYDROFOLATE SALT AND METHOD FOR PREPARING SAME' [patent_app_type] => utility [patent_app_number] => 14/373262 [patent_app_country] => US [patent_app_date] => 2012-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6315 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968857 [patent_doc_number] => 08507668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid' [patent_app_type] => utility [patent_app_number] => 13/714950 [patent_app_country] => US [patent_app_date] => 2012-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1081 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13714950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10281516 [patent_doc_number] => 20150166514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'INHIBITORS OF HCV NS5A' [patent_app_type] => utility [patent_app_number] => 14/364818 [patent_app_country] => US [patent_app_date] => 2012-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15271 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14364818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10920430 [patent_doc_number] => 20140323450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'COMBINATION COMPOSITIONS AND METHODS OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/363730 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17206 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854378 [patent_doc_number] => 20130144053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'Process for the Production of Seven-Membered Lactam Morphinans' [patent_app_type] => utility [patent_app_number] => 13/705205 [patent_app_country] => US [patent_app_date] => 2012-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7017 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13705205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8755216 [patent_doc_number] => 20130089520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'Macrocyclic Inhibitors Of Hepatitis C Virus' [patent_app_type] => utility [patent_app_number] => 13/687037 [patent_app_country] => US [patent_app_date] => 2012-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40247 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13687037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9175059 [patent_doc_number] => 20130317044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'NOVEL CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE' [patent_app_type] => utility [patent_app_number] => 13/686182 [patent_app_country] => US [patent_app_date] => 2012-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13644 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13686182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9120771 [patent_doc_number] => 20130287692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'RIFAMYCIN DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/684803 [patent_app_country] => US [patent_app_date] => 2012-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13867 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13684803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9108565 [patent_doc_number] => 20130281697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN' [patent_app_type] => utility [patent_app_number] => 13/680967 [patent_app_country] => US [patent_app_date] => 2012-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4984 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9778025 [patent_doc_number] => 08853231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin' [patent_app_type] => utility [patent_app_number] => 13/679602 [patent_app_country] => US [patent_app_date] => 2012-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5866 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13679602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216342 [patent_doc_number] => 08629142 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Modulators of toll-like receptors' [patent_app_type] => utility [patent_app_number] => 13/679803 [patent_app_country] => US [patent_app_date] => 2012-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68936 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13679803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10920450 [patent_doc_number] => 20140323471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'POLYMORPHIC FORMS OF IVABRADINE HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 14/358025 [patent_app_country] => US [patent_app_date] => 2012-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5959 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982295 [patent_doc_number] => 08513410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid' [patent_app_type] => utility [patent_app_number] => 13/673145 [patent_app_country] => US [patent_app_date] => 2012-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3222 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13673145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9671989 [patent_doc_number] => 20140235852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'PROCESS FOR PREPARING AN INTERMEDIATE OF THE MACROCYCLIC PROTEASE INHIBITOR TMC 435' [patent_app_type] => utility [patent_app_number] => 14/350138 [patent_app_country] => US [patent_app_date] => 2012-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6738 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10912898 [patent_doc_number] => 20140315916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'MACROCYCLES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/354303 [patent_app_country] => US [patent_app_date] => 2012-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22238 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582472 [patent_doc_number] => 08772476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Gas and liquid phase catalytic Beckmann rearrangement of oximes to produce lactams' [patent_app_type] => utility [patent_app_number] => 13/658495 [patent_app_country] => US [patent_app_date] => 2012-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 35 [patent_no_of_words] => 11789 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13658495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8685286 [patent_doc_number] => 20130053570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'CGRP Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 13/652690 [patent_app_country] => US [patent_app_date] => 2012-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23221 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13652690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670484 [patent_doc_number] => 20140234346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'PYRROLOBENZODIAZEPINES' [patent_app_type] => utility [patent_app_number] => 14/351175 [patent_app_country] => US [patent_app_date] => 2012-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22611 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9756269 [patent_doc_number] => 20140286970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'PYRROLOBENZODIAZEPINES AND TARGETED CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/351168 [patent_app_country] => US [patent_app_date] => 2012-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27673 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9756269 [patent_doc_number] => 20140286970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'PYRROLOBENZODIAZEPINES AND TARGETED CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/351168 [patent_app_country] => US [patent_app_date] => 2012-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27673 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351168 [rel_patent_id] =>[rel_patent_doc_number] =>)